APO Research
Talk to an analyst

APO RESEARCH · REPORT

Painkillers

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Painkillers Market Outlook and Growth Opportunities 2026

26 December 2025199 pages

Choose your research edition.

Industry ResearchPainkillers Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Painkillers Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Painkillers Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Painkillers Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Painkillers Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Painkillers market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Painkillers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Painkillers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Painkillers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Painkillers market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Painkillers market include Sanofi, Johnson & Johnson, Johnson & Johnson, Novartis, Merck, Roche, Eli Lilly, Pfizer and Purdue Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Painkillers market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Painkillers and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Painkillers sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Painkillers market size, projected growth trends, production technologies, key applications, and end-use industries.

Painkillers Segment by Company

Sanofi

Johnson & Johnson

Johnson & Johnson

Novartis

Merck

Roche

Eli Lilly

Pfizer

Purdue Pharma

Novavax

GlaxoSmithKline

Celgene

Astrazeneca

Painkillers Segment by Type

Opioids

Aspirin and NSAIDs

Paracetamol

Painkillers Segment by Application

Dental Pain

Trauma

Headache

Dysmenorrhoea (Painful Menstruation)

Bone Pain

Arthritis

Painkillers Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Painkillers status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Painkillers market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Painkillers significant trends, drivers, influence factors in global and regions.

6. To analyze Painkillers competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Painkillers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Painkillers and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Painkillers.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Painkillers market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Painkillers industry.

Chapter 3: Detailed analysis of Painkillers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Painkillers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Painkillers in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Painkillers Industry Trends Table 2. Painkillers Industry Drivers Table 3. Painkillers Industry Opportunities and Challenges Table 4. Painkillers Industry Restraints Table 5. Global Painkillers Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Painkillers Revenue Share by Company (2021-2026) Table 7. Global Painkillers Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Painkillers Sales Volume Share by Company (2021-2026) Table 9. Global Painkillers Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Painkillers Company Ranking, (2024-2026) & (USD Million) Table 11. Global Painkillers Key Company Manufacturing Base & Headquarters Table 12. Global Painkillers Company, Product Type & Application Table 13. Global Painkillers Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Painkillers by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Opioids Table 18. Significant Companies of Aspirin and NSAIDs Table 19. Significant Companies of Paracetamol Table 20. Global Painkillers Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 21. Global Painkillers Sales Volume by Type (2021-2026) & (W Units) Table 22. Global Painkillers Sales Volume by Type (2027-2032) & (W Units) Table 23. Global Painkillers Sales Volume Share by Type (2021-2026) Table 24. Global Painkillers Sales Volume Share by Type (2027-2032) Table 25. Global Painkillers Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Painkillers Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Painkillers Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Painkillers Sales Value Share by Type (2021-2026) Table 29. Global Painkillers Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Dental Pain Table 31. Significant Companies of Trauma Table 32. Significant Companies of Headache Table 33. Significant Companies of Dysmenorrhoea (Painful Menstruation) Table 34. Significant Companies of Bone Pain Table 35. Significant Companies of Arthritis Table 36. Global Painkillers Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 37. Global Painkillers Sales Volume by Application (2021-2026) & (W Units) Table 38. Global Painkillers Sales Volume by Application (2027-2032) & (W Units) Table 39. Global Painkillers Sales Volume Share by Application (2021-2026) Table 40. Global Painkillers Sales Volume Share by Application (2027-2032) Table 41. Global Painkillers Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Painkillers Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global Painkillers Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global Painkillers Sales Value Share by Application (2021-2026) Table 45. Global Painkillers Sales Value Share by Application (2027-2032) Table 46. Global Painkillers Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 47. Global Painkillers Sales by Region (2021-2026) & (W Units) Table 48. Global Painkillers Sales Market Share by Region (2021-2026) Table 49. Global Painkillers Sales by Region (2027-2032) & (W Units) Table 50. Global Painkillers Sales Market Share by Region (2027-2032) Table 51. Global Painkillers Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Painkillers Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global Painkillers Sales Value Share by Region (2021-2026) Table 54. Global Painkillers Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global Painkillers Sales Value Share by Region (2027-2032) Table 56. Global Painkillers Market Average Price (US$/Unit) by Region (2021-2026) Table 57. Global Painkillers Market Average Price (US$/Unit) by Region (2027-2032) Table 58. Global Painkillers Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 59. Global Painkillers Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Painkillers Sales by Country (2021-2026) & (W Units) Table 61. Global Painkillers Sales Market Share by Country (2021-2026) Table 62. Global Painkillers Sales by Country (2027-2032) & (W Units) Table 63. Global Painkillers Sales Market Share by Country (2027-2032) Table 64. Global Painkillers Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global Painkillers Sales Value Market Share by Country (2021-2026) Table 66. Global Painkillers Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global Painkillers Sales Value Market Share by Country (2027-2032) Table 68. Sanofi Company Information Table 69. Sanofi Business Overview Table 70. Sanofi Painkillers Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Sanofi Painkillers Product Portfolio Table 72. Sanofi Recent Development Table 73. Johnson & Johnson Company Information Table 74. Johnson & Johnson Business Overview Table 75. Johnson & Johnson Painkillers Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Johnson & Johnson Painkillers Product Portfolio Table 77. Johnson & Johnson Recent Development Table 78. Johnson & Johnson Company Information Table 79. Johnson & Johnson Business Overview Table 80. Johnson & Johnson Painkillers Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Johnson & Johnson Painkillers Product Portfolio Table 82. Johnson & Johnson Recent Development Table 83. Novartis Company Information Table 84. Novartis Business Overview Table 85. Novartis Painkillers Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Novartis Painkillers Product Portfolio Table 87. Novartis Recent Development Table 88. Merck Company Information Table 89. Merck Business Overview Table 90. Merck Painkillers Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Merck Painkillers Product Portfolio Table 92. Merck Recent Development Table 93. Roche Company Information Table 94. Roche Business Overview Table 95. Roche Painkillers Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Roche Painkillers Product Portfolio Table 97. Roche Recent Development Table 98. Eli Lilly Company Information Table 99. Eli Lilly Business Overview Table 100. Eli Lilly Painkillers Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Eli Lilly Painkillers Product Portfolio Table 102. Eli Lilly Recent Development Table 103. Pfizer Company Information Table 104. Pfizer Business Overview Table 105. Pfizer Painkillers Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Pfizer Painkillers Product Portfolio Table 107. Pfizer Recent Development Table 108. Purdue Pharma Company Information Table 109. Purdue Pharma Business Overview Table 110. Purdue Pharma Painkillers Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Purdue Pharma Painkillers Product Portfolio Table 112. Purdue Pharma Recent Development Table 113. Novavax Company Information Table 114. Novavax Business Overview Table 115. Novavax Painkillers Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Novavax Painkillers Product Portfolio Table 117. Novavax Recent Development Table 118. GlaxoSmithKline Company Information Table 119. GlaxoSmithKline Business Overview Table 120. GlaxoSmithKline Painkillers Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. GlaxoSmithKline Painkillers Product Portfolio Table 122. GlaxoSmithKline Recent Development Table 123. Celgene Company Information Table 124. Celgene Business Overview Table 125. Celgene Painkillers Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Celgene Painkillers Product Portfolio Table 127. Celgene Recent Development Table 128. Astrazeneca Company Information Table 129. Astrazeneca Business Overview Table 130. Astrazeneca Painkillers Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Astrazeneca Painkillers Product Portfolio Table 132. Astrazeneca Recent Development Table 133. Key Raw Materials Table 134. Raw Materials Key Suppliers Table 135. Painkillers Distributors List Table 136. Painkillers Customers List Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Painkillers Product Image Figure 2. Global Painkillers Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Painkillers Sales Value (2021-2032) & (US$ Million) Figure 4. Global Painkillers Sales (2021-2032) & (W Units) Figure 5. Global Painkillers Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Painkillers Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Opioids Image Figure 10. Aspirin and NSAIDs Image Figure 11. Paracetamol Image Figure 12. Global Painkillers Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 13. Global Painkillers Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Painkillers Sales Volume Share by Type (2021-2032) Figure 15. Global Painkillers Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Painkillers Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Painkillers Sales Value Share by Type (2021-2032) Figure 18. Dental Pain Image Figure 19. Trauma Image Figure 20. Headache Image Figure 21. Dysmenorrhoea (Painful Menstruation) Image Figure 22. Bone Pain Image Figure 23. Arthritis Image Figure 24. Global Painkillers Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 25. Global Painkillers Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global Painkillers Sales Volume Share by Application (2021-2032) Figure 27. Global Painkillers Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Painkillers Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global Painkillers Sales Value Share by Application (2021-2032) Figure 30. Global Painkillers Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 31. Global Painkillers Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global Painkillers Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global Painkillers Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America Painkillers Sales Value (2021-2032) & (US$ Million) Figure 35. North America Painkillers Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe Painkillers Sales Value (2021-2032) & (US$ Million) Figure 37. Europe Painkillers Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific Painkillers Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Painkillers Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America Painkillers Sales Value (2021-2032) & (US$ Million) Figure 41. South America Painkillers Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa Painkillers Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa Painkillers Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Painkillers Value Chain Figure 129. Manufacturing Cost Structure Figure 130. Painkillers Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • Opioids
  • Aspirin and NSAIDs
  • Paracetamol
Applications
  • Dental Pain
  • Trauma
  • Headache
  • Dysmenorrhoea (Painful Menstruation)
  • Bone Pain
  • Arthritis
Companies covered
  • Sanofi
  • Johnson & Johnson
  • Johnson & Johnson
  • Novartis
  • Merck
  • Roche
  • Eli Lilly
  • Pfizer
  • Purdue Pharma
  • Novavax
  • GlaxoSmithKline
  • Celgene
  • Astrazeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Painkillers Sales Value (2021-2032)
  4. 1.2.2 Global Painkillers Sales Volume (2021-2032)
  5. 1.2.3 Global Painkillers Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Painkillers Market Dynamics
  1. 2.1 Painkillers Industry Trends
  2. 2.2 Painkillers Industry Drivers
  3. 2.3 Painkillers Industry Opportunities and Challenges
  4. 2.4 Painkillers Industry Restraints
3 Painkillers Market by Company
  1. 3.1 Global Painkillers Company Revenue Ranking in 2025
  2. 3.2 Global Painkillers Revenue by Company (2021-2026)
  3. 3.3 Global Painkillers Sales Volume by Company (2021-2026)
  4. 3.4 Global Painkillers Average Price by Company (2021-2026)
  5. 3.5 Global Painkillers Company Ranking (2024-2026)
  6. 3.6 Global Painkillers Company Manufacturing Base and Headquarters
  7. 3.7 Global Painkillers Company Product Type and Application
  8. 3.8 Global Painkillers Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Painkillers Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Painkillers Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Painkillers Market by Type
  1. 4.1 Painkillers Type Introduction
  2. 4.1.1 Opioids
  3. 4.1.2 Aspirin and NSAIDs
  4. 4.1.3 Paracetamol
  5. 4.2 Global Painkillers Sales Volume by Type
  6. 4.2.1 Global Painkillers Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Painkillers Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Painkillers Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Painkillers Sales Value by Type
  10. 4.3.1 Global Painkillers Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Painkillers Sales Value by Type (2021-2032)
  12. 4.3.3 Global Painkillers Sales Value Share by Type (2021-2032)
5 Painkillers Market by Application
  1. 5.1 Painkillers Application Introduction
  2. 5.1.1 Dental Pain
  3. 5.1.2 Trauma
  4. 5.1.3 Headache
  5. 5.1.4 Dysmenorrhoea (Painful Menstruation)
  6. 5.1.5 Bone Pain
  7. 5.1.6 Arthritis
  8. 5.2 Global Painkillers Sales Volume by Application
  9. 5.2.1 Global Painkillers Sales Volume by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Painkillers Sales Volume by Application (2021-2032)
  11. 5.2.3 Global Painkillers Sales Volume Share by Application (2021-2032)
  12. 5.3 Global Painkillers Sales Value by Application
  13. 5.3.1 Global Painkillers Sales Value by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global Painkillers Sales Value by Application (2021-2032)
  15. 5.3.3 Global Painkillers Sales Value Share by Application (2021-2032)
6 Painkillers Regional Sales and Value Analysis
  1. 6.1 Global Painkillers Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Painkillers Sales by Region (2021-2032)
  3. 6.2.1 Global Painkillers Sales by Region: 2021-2026
  4. 6.2.2 Global Painkillers Sales by Region (2027-2032)
  5. 6.3 Global Painkillers Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Painkillers Sales Value by Region (2021-2032)
  7. 6.4.1 Global Painkillers Sales Value by Region: 2021-2026
  8. 6.4.2 Global Painkillers Sales Value by Region (2027-2032)
  9. 6.5 Global Painkillers Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Painkillers Sales Value (2021-2032)
  12. 6.6.2 North America Painkillers Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Painkillers Sales Value (2021-2032)
  15. 6.7.2 Europe Painkillers Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Painkillers Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Painkillers Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Painkillers Sales Value (2021-2032)
  21. 6.9.2 South America Painkillers Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Painkillers Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Painkillers Sales Value Share by Country, 2025 VS 2032
7 Painkillers Country-level Sales and Value Analysis
  1. 7.1 Global Painkillers Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Painkillers Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Painkillers Sales by Country (2021-2032)
  4. 7.3.1 Global Painkillers Sales by Country (2021-2026)
  5. 7.3.2 Global Painkillers Sales by Country (2027-2032)
  6. 7.4 Global Painkillers Sales Value by Country (2021-2032)
  7. 7.4.1 Global Painkillers Sales Value by Country (2021-2026)
  8. 7.4.2 Global Painkillers Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Painkillers Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Painkillers Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Painkillers Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Painkillers Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Painkillers Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Painkillers Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Painkillers Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Painkillers Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Painkillers Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Painkillers Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Painkillers Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Painkillers Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Painkillers Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Painkillers Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Painkillers Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Painkillers Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Painkillers Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Painkillers Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Painkillers Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Painkillers Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Painkillers Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Painkillers Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Painkillers Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Painkillers Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Painkillers Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Painkillers Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Painkillers Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Painkillers Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Painkillers Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Painkillers Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Painkillers Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Painkillers Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Painkillers Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Painkillers Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Painkillers Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Painkillers Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Painkillers Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Painkillers Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Painkillers Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Painkillers Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Painkillers Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Painkillers Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Painkillers Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Painkillers Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Painkillers Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Painkillers Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Painkillers Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Painkillers Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Painkillers Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Painkillers Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Painkillers Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Painkillers Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Painkillers Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Painkillers Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Painkillers Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Painkillers Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Painkillers Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Painkillers Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Painkillers Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Painkillers Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Painkillers Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Painkillers Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Painkillers Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Painkillers Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Painkillers Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Painkillers Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Painkillers Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Painkillers Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Painkillers Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Painkillers Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Painkillers Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Painkillers Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Painkillers Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Painkillers Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Painkillers Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Painkillers Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Painkillers Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Painkillers Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Painkillers Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Painkillers Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Painkillers Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Painkillers Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Painkillers Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Painkillers Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Painkillers Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Painkillers Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Painkillers Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Painkillers Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Johnson & Johnson
  14. 8.3.1 Johnson & Johnson Company Information
  15. 8.3.2 Johnson & Johnson Business Overview
  16. 8.3.3 Johnson & Johnson Painkillers Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Johnson & Johnson Painkillers Product Portfolio
  18. 8.3.5 Johnson & Johnson Recent Developments
  19. 8.4 Novartis
  20. 8.4.1 Novartis Company Information
  21. 8.4.2 Novartis Business Overview
  22. 8.4.3 Novartis Painkillers Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Novartis Painkillers Product Portfolio
  24. 8.4.5 Novartis Recent Developments
  25. 8.5 Merck
  26. 8.5.1 Merck Company Information
  27. 8.5.2 Merck Business Overview
  28. 8.5.3 Merck Painkillers Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Merck Painkillers Product Portfolio
  30. 8.5.5 Merck Recent Developments
  31. 8.6 Roche
  32. 8.6.1 Roche Company Information
  33. 8.6.2 Roche Business Overview
  34. 8.6.3 Roche Painkillers Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Roche Painkillers Product Portfolio
  36. 8.6.5 Roche Recent Developments
  37. 8.7 Eli Lilly
  38. 8.7.1 Eli Lilly Company Information
  39. 8.7.2 Eli Lilly Business Overview
  40. 8.7.3 Eli Lilly Painkillers Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Eli Lilly Painkillers Product Portfolio
  42. 8.7.5 Eli Lilly Recent Developments
  43. 8.8 Pfizer
  44. 8.8.1 Pfizer Company Information
  45. 8.8.2 Pfizer Business Overview
  46. 8.8.3 Pfizer Painkillers Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Pfizer Painkillers Product Portfolio
  48. 8.8.5 Pfizer Recent Developments
  49. 8.9 Purdue Pharma
  50. 8.9.1 Purdue Pharma Company Information
  51. 8.9.2 Purdue Pharma Business Overview
  52. 8.9.3 Purdue Pharma Painkillers Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Purdue Pharma Painkillers Product Portfolio
  54. 8.9.5 Purdue Pharma Recent Developments
  55. 8.10 Novavax
  56. 8.10.1 Novavax Company Information
  57. 8.10.2 Novavax Business Overview
  58. 8.10.3 Novavax Painkillers Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Novavax Painkillers Product Portfolio
  60. 8.10.5 Novavax Recent Developments
  61. 8.11 GlaxoSmithKline
  62. 8.11.1 GlaxoSmithKline Company Information
  63. 8.11.2 GlaxoSmithKline Business Overview
  64. 8.11.3 GlaxoSmithKline Painkillers Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 GlaxoSmithKline Painkillers Product Portfolio
  66. 8.11.5 GlaxoSmithKline Recent Developments
  67. 8.12 Celgene
  68. 8.12.1 Celgene Company Information
  69. 8.12.2 Celgene Business Overview
  70. 8.12.3 Celgene Painkillers Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Celgene Painkillers Product Portfolio
  72. 8.12.5 Celgene Recent Developments
  73. 8.13 Astrazeneca
  74. 8.13.1 Astrazeneca Company Information
  75. 8.13.2 Astrazeneca Business Overview
  76. 8.13.3 Astrazeneca Painkillers Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Astrazeneca Painkillers Product Portfolio
  78. 8.13.5 Astrazeneca Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Painkillers Value Chain Analysis
  2. 9.1.1 Painkillers Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Painkillers Sales Mode & Process
  6. 9.2 Painkillers Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Painkillers Distributors
  9. 9.2.3 Painkillers Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst